Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prognostic Implications of RV-Arterial Coupling Estimated by CMR in a Large Cohort of Tricuspid Regurgitation Patients.

Circulation. Cardiovascular imaging·2026
Same author

Improving structural heart disease screening: AI-ECG and novice AI-guided focused cardiac ultrasound.

NPJ digital medicine·2026
Same author

Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials.

Circulation·2026
Same author

Smarter FoCUS: AI-guided focused cardiac ultrasound enables novice detection of left ventricular dysfunction.

European heart journal. Digital health·2026
Same author

Quantitative Analysis of the Impact of Region of Interest Information on Deep Learning Algorithms for Thyroid Ultrasound Imaging.

IEEE open journal of engineering in medicine and biology·2026
Same author

BRD2 upregulation as a pan-cancer adaptive resistance mechanism to BET inhibition.

Cellular & molecular biology letters·2026
Same journal

Reply to the letter: 'multimodality imaging in cardio-oncology: from detection to actionable management to the editor'.

European heart journal. Cardiovascular Imaging·2026
Same journal

Incremental Prognostic Value of Cardiac Magnetic Resonance Beyond Biomarker Staging in Transthyretin Cardiac Amyloidosis.

European heart journal. Cardiovascular Imaging·2026
Same journal

Reference Framework for Implementation of Cardiovascular Imaging in Clinical Trials. A Scientific Statement of the European Association of Cardiovascular Imaging (EACVI) of the ESC.

European heart journal. Cardiovascular Imaging·2026
Same journal

Left atrial intramural hematoma secondary to ethanol infusion of the vein of marshall.

European heart journal. Cardiovascular Imaging·2026
Same journal

CMR Predictors of Liver Cirrhosis by MRI in a National Paediatric Fontan Cohort.

European heart journal. Cardiovascular Imaging·2026
Same journal

Septic Coronary Embolism in Prosthetic Endocarditis: Spectral CT Establishes Embolic Origin.

European heart journal. Cardiovascular Imaging·2026
See all related articles

Related Experiment Videos

Decoding the Complexity of Tricuspid Regurgitation Prognostic Drivers Using Explainable Artificial Intelligence.

Gal Tsaban1, Giovanni Benfari1,2, Benjamin A Essayagh1,3

  • 1Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

European Heart Journal. Cardiovascular Imaging
|June 27, 2026
PubMed
Summary
This summary is machine-generated.

Explainable AI identified key predictors of mortality in tricuspid regurgitation (TR), revealing hemodynamics and right-ventricular dysfunction as crucial factors. This improves risk stratification for better patient management.

Related Experiment Videos

Area of Science:

  • Cardiology
  • Artificial Intelligence
  • Medical Prognostics

Background:

  • Tricuspid regurgitation (TR) prognosis is complex due to intricate clinical and hemodynamic interactions, challenging accurate risk stratification.
  • Current methods may not fully capture the multifactorial nature of TR outcomes.

Purpose of the Study:

  • To employ explainable artificial intelligence (EAI) to model TR prognosis.
  • To identify and rank key predictors of mortality in patients with TR across the full severity spectrum.

Main Methods:

  • Analysis of a large prospective registry of 9,761 patients with native TR.
  • Application of supervised EAI models to identify non-linear associations and interactions among baseline characteristics.
  • Quantitative Doppler-echocardiography and detailed clinical evaluation.

Main Results:

  • EAI identified 20 prognostic determinants of mortality, with hemodynamic measures (pulmonary-artery systolic and right-atrial pressures) being most significant.
  • Right-ventricular dysfunction and effective regurgitant orfice area (EROA) were stronger TR-specific predictors than integrated scores.
  • Non-linear effects and interactions (e.g., EROA with pulmonary pressures) influenced survival.

Conclusions:

  • EAI effectively ranked mortality predictors in TR, emphasizing hemodynamics, patient factors, and TR-specific measures.
  • Effective regurgitant orfice area (EROA) emerged as a strong TR severity marker, with increased mortality observed at 40mm² and 60mm².
  • These findings can refine risk stratification, guide intervention timing, and inform long-term management strategies for TR.